trending Market Intelligence /marketintelligence/en/news-insights/trending/1402WtuK-Bbr3yVPxEcKaw2 content esgSubNav
In This List

Fuse Medical makes leadership changes following investment

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Fuse Medical makes leadership changes following investment

Christopher Reeg was appointed the CEO of Fuse Medical Inc. after he made an equity investment in the company.

Reeg acquired 4 million shares of the company for $320,000. He was joined by Mark Brooks who purchased 5 million shares for $400,000 and was appointed the chairman of the board.

Brooks and Reeg now own 57% of the company and replace Christopher Pratt and Robert Donehew, Fuse Medical's former CEO and board chairman, respectively.

The company's board size was also increased to five members. Pratt and Donehew will remain on the board and will be joined by Brooks and Reeg.

William McLaughlin III, a nominee of Brooks and Reeg, is also joining the board. Rusty Shelton and Randall Dei have resigned to make way for the additions.

Reeg is the founder and president of Maxim Surgical, which is in the business of spinal and orthopedic implants. Brooks is the CEO and McLaughlin is the CFO of CPM Medical Consultants LLC, a distributor of medical devices and regenerative tissue.